首页> 外文期刊>Histopathology: Official Journal of the British Division of the International Academy of Pathology >Acute leukaemia with a pure erythroid phenotype: under-recognized morphological and cytogenetic signatures associated universally with primary refractory disease and a dismal clinical outcome
【24h】

Acute leukaemia with a pure erythroid phenotype: under-recognized morphological and cytogenetic signatures associated universally with primary refractory disease and a dismal clinical outcome

机译:急性白血病,纯度红细胞表型:公认的形态学和细胞遗传学签名均普遍伴有初级难治性疾病和令人沮丧的临床结果

获取原文
获取原文并翻译 | 示例
           

摘要

AimsPure erythroid leukaemia (PEL) is an extremely rare and aggressive subtype of acute myeloid leukaemia defined by the World Health Organization (WHO) as a neoplastic proliferation of immature cells committed exclusively to the erythroid lineage, comprising >80% of bone marrow cells and not meeting the criteria of other well-defined myeloid neoplasms. The aim of this study was to describe the clinicopathological features of acute leukaemias with a pure erythroid phenotype (ALPEP) irrespective of their WHO classification and to determine if ALPEP represents a distinct clinicopathological entity.
机译:AIMSPURE红细胞白血病(PEL)是由世界卫生组织(WHO)定义的一种极其罕见和侵蚀的亚型,由世界卫生组织(世卫组织)为未成熟细胞的肿瘤增殖仅针对红细胞谱系,包含> 80%的骨髓细胞而不是 符合其他明确定义明确髓样肿瘤的标准。 本研究的目的是描述急性白血病的临床病理特征,其具有纯红细胞表型(ALPEP),而不论他们的分类如何,并确定ALPEP是否代表明显的临床病理实体。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号